Skip to main content
. 2017 Mar 21;27(5):520–530. doi: 10.5301/ejo.5000952

Fig. 5.

Fig. 5

Post hoc analysis of the percentage of co-responders in both signs and symptoms of dry eye disease after 6 months of randomized treatment with 0.1% cyclosporine A cationic emulsion (CsA CE) or vehicle according to corneal fluorescein staining (CFS) scores at baseline. Data represent the full analysis set. Co-responders were defined as those having ≥2 points improvement in CFS score and ≥30% improvement in Ocular Surface Disease Index score. The statistical comparisons shown reflect the results of chi-square tests.